Analysis of dosimetric parameters of acute radiation enteritis in cervical cancer patients treated with con-current chemoradiotherapy
10.3969/j.issn.1006-5725.2024.05.014
- VernacularTitle:宫颈癌同步放化疗急性放射性肠炎的剂量学参数分析
- Author:
Jing HU
1
;
Xu WANG
;
Xiaoqin GONG
;
Rui LING
;
Tao YOU
;
Chunhua DAI
;
Ye TIAN
;
Fei CHEN
Author Information
1. 江苏大学附属医院放疗科(江苏镇江 212000)
- Keywords:
cervical cancer;
concurrent chemoradiotherapy;
acute radiation enteritis;
dosimetric
- From:
The Journal of Practical Medicine
2024;40(5):672-676
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the correlation between intestinal dose and acute radiation enteritis(ARE)in patients with cervical cancer received concurrent chemoradiotherapy,and optimize the dose limit of intestinal tissue.Methods 158 cervical cancer patients received concurrent chemoradiotherapy from 2014 to 2019 were selected in this study.According to CTCAE 5.0,patients with ARE≥grade 2 were classified as ARE≥grade 2 group,otherwise classified as ARE0.7,P<0.05).Conclusions For patients with cervical cancer received concurrent chemoradiotherapy,the dose of bowelbag V5 and V40 should be considered to rationally optimize the dose of bowelbag in the radiotherapy plan,so as to reduce the incidence of ARE≥grade 2.
